WHO and Research in Natural Family Planning by Lanctot, Claude A.
The Linacre Quarterly
Volume 45 | Number 4 Article 13
November 1978
WHO and Research in Natural Family Planning
Claude A. Lanctot
Follow this and additional works at: http://epublications.marquette.edu/lnq
Recommended Citation
Lanctot, Claude A. (1978) "WHO and Research in Natural Family Planning," The Linacre Quarterly: Vol. 45: No. 4, Article 13.
Available at: http://epublications.marquette.edu/lnq/vol45/iss4/13
WHO and Research 
in Natural Family Planning 
Claude A. Lanctot, M.D., M.P.H. 
Dr. Lanctot, an obstetrician-gynecologist, is a member of the steer-
ing committee of the WHO Task Force on the Methods for the 
Determination of the Fertile Period. On leave of absence from the 
University of Sherbrooke in Quebec, he is the full-time executive 
director of the International Federation for Family Life Promotion. 
This report has been prepared from the annual report of the WHO 
Special Program of Research in Human Reproduction. 
The World Health Organization Special Program of Research , Devel-
opment and Research Training in Human Reproduction was estab-
lished in 1972. In five years, it has grown to an annual fifteen million 
dollar program involving scientists from 69 countries including 45 
developing countries, largely supported by voluntary contributions 
from member states) Having been closely involved with the task force 
for the methods for the determination of the fertile period, it is my 
pleasure to present for WHO an overview of its research work in 
human reproduction and on t he fertile period in particular. 
The Special Program addresses itself to all aspects of research in 
human reproduction including pregnancy, labor, lactation, fetal 
wastage and infertility . However, the major emphasis of the program is 
on the regulation of fertility2 where the principal objectives are: 
- to provide WHO member states with a variety of safe, effective 
and acceptable fertility regulating methods to meet differing 
needs and different situations, and to assist national authorities 
in devising the best ways of providing these methods on a contin-
uing basis ; 
- to strengthen the resources for research in this field, particularly 
in developing countries, and also to build up, on a world-wide 
basis, the needed disciplines . 
Research in the program is primarily conducted through task forces 
which are multidisciplinary groups of scientists from different coun-
tries and different institutions. Each of these mission-oriented groups 
is focusing on specific approaches to fertility regulation, bringing 
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· together whatever skills and facilities are required to achieve a given 
objective in the shortest possible time. 
At present there are 17 task forces supporting research on a vari-
ety of methods that include pills for women and men; injectable 
preparations, again for both sexes; intra-uterine devices; methods 
based on periodic abstinence; sterilization; termination of pregnancy; 
post-coital preparations; and birth control vaccines. 
I have been asked to speak about the work of the Task Force on 
Methods for the Determination of the Fertile Period as the WHO staff 
member (Mr. J. Spieler) responsible for this activity was unable to attend 
this meeting. Reasearch in this task force aims at: 
1. assessing in different countries and cultures the currently avail-
able methods based on periodic abstinence; 
2. improving the service delivery of these methods; 
3. evaluating physiological parameters which determine the dura-
tion of the fertile period; 
4. developing assay kits and devices for predicting and detecting the 
time of ovulation. 
Methods based on periodic abstinence appeal to persons who wish 
to capitalize on knowledge of the fertile and infertile phases of their 
menstrual cycle for their approach to family planning, and/or who do 
not wish to use drugs or devices either because they are concerned 
about their side effects or for religious or other reasons. Since there is 
controversy on the effectiveness of methods based on periodic absti-
nence, even when a considerable effort is made in motivation and 
teaching, family planning administrators have hesitated to include 
them in national programs despite their apparent advantages in terms 
of cost and simplicity of delivery . 
The appeal of such methods would perhaps increase if techniques 
were developed to permit women to determine objectively and pre-
cisely the fertile and infertile phases of the menstrual cycle. The devel-
opment of simple "do-it-yourself" methods for distinguishing these 
phases should: 
1. enhance the effectiveness and perhaps simplify the use of 
methods based solely on periodic abstinence; 
2. allow couples who use certain methods of fertility regulation 
such as the condom, diaphragm and coitus interruptus, to limit 
these to the days of the fertile period; 
3. allow the use of other new methods which are being developed; 
e.g., post-coital agents, to be restricted to the ovulatory period; 
and 
4. improve the time of intercourse for conception when pregnancy 
is desired (especially for infertile couples). 
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Assessment of currently available methods 
based on periodic abstinence 
Basically there are four main methods of fertility regulation based 
on periodic abstinence: the calendar method (rhythm); the tempera-
ture method (BBT); cervical mucus methods (eM), e.g., the ovulation 
method (OM) and sympto-thermal method(s) (S-TM). The first 
method is considered obsolete by most workers in this field because it 
does not take into consideration normal biological variation and thus 
does not offer a satisfactory level of protection against unplanned 
pregnancies. Although the BBT method alone is relatively effective if 
intercourse is confined to the postovulatory phase of the menstrual 
cycle, the degree of abstinence required, especially during long or 
anovulatory cycles, detracts from its use and acceptability. The cer-
vical mucus methods are based on the changes during the menstrual 
cycle in the quantity and quality of cervical mucus which may be 
subjectively assessed by women. The sympto-thermal method basically 
relies on a variety of indications of ovulation including cervical mucus 
changes, mittelschmerz, calendar calculations, etc., combined with 
BBT measurements. In certain circumstances the sympto-thermal 
method may be more suitable for a given woman than a cervical 
mucus method alone, e.g., when difficulty in assessing the changing 
characteristics of the mucus is experienced. On the other hand, for 
women using a sympto-thermal method who find that the mucus 
symptom and BBT end-points which signal the beginning of the post-
ovulatory infertile phase coincide, perhaps the somewhat tedious task 
of temperature-taking and recording can be abandoned. Nevertheless, 
the effectiveness of these methods has not yet been unequivocally 
determined, although it appears to depend greatly upon the motiva-
tion of the couple, the quality of the teaching of the methods and the 
regularity of the phenomena monitored in different women. 
In August, 1976, subject recruitment began for a multicenter clin-
ical evaluation of the ovulation method (Billings). Specifically the 
study is attempting to: 
- determine the percentage of women capable of recognizing 
changes in cervical mucus during the menstrual cycle; 
- correlate in a selected number of cycles the changes in cervical 
mucus with an objective parameter of ovulation, namely pro-
gesterone levels; 
- correlate the ability or inability of women to observe cervical 
mucus changes with social and medical data available for the 
subjects; 
- determine the theoretical effectiveness and use-effectiveness of 
the method in subjects who are capable of detecting changes in 
the cervical mucus. 
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In order to obtain a cross-cultural assessment of this method, 
centers were selected in EI Salvador, Ireland, India, New Zealand and 
the Philippines. The centers were chosen from among those which had 
previous experience in the method being studied and available quali-
fied teachers. Some special features of the study include: 
- selection of women (150-200 subjects per center) who had not 
previously practiced a cervical mucus method and who were of 
proven fertility in their marriage /union; 
- the inclusion of only " normal" ovulatory women with regular 
menstrual cycles of intervals between 23-35 days; 
- successful completion of a three to five month training period 
before entry into the main part of the effectiveness study; 
- inclusion of subjects from both urban and rural settings at each 
center. 
On May 16-19, at the Task Force Steering Committee meeting in 
Geneva, Dr. Henry Burger, coordinator of the study, presented these 
preliminary findings: 
a. The teaching phase (first three months) has a sufficient number of 
analyzed results to indicate significant findings, namely: 
- in the first teaching cycle, 95% of charts showed interpretable 
mucus patterns; 
- within the first three teaching cycles, 90% of the subjects were 
interpreted as producing good or excellent records. 
h. The effectiveness phase of the study: Not yet half of the data has 
been returned and analyzed and it therefore appears premature to 
present any significant findings. Yet, as a trend, it is interesting that 
when the conception records of 86 pregnancies occurring in either 
the teaching or early effectiveness phase were looked at, only 5 
could be definitely classified as method failures. 
Final results of the teaching phase should be ready around Novem-
ber or December, 1978. 
The steering committee, impressed by this low method failure rate 
confirming the results of other studies, recommended that an inter-
study comparison and analysis of all pregnancies and dropouts be 
undertaken to better delineate this phenomenon. 
The task force is also supporting a study in Colombia which aims at 
comparing in 500 randomized subjects the effectiveness of the ovula-
tion method with that of one form of the sympto-thermal method in 
two cities (Bogota and Cali) and through different health service chan-
nels. The investigators in Colombia have experienced more difficulty 
than they anticipated in recruiting couples for this study. Although 
preliminary data were presented and discussed in Geneva, these appear 
too incomplete for any significant presentation at this time. The drop-
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out rates were very high during the study and no significant differ-
ences are evident between the O.M. and S.T. method effectiveness in 
the Colombia part of the study. These findings should be more 
complete one year from now. 
Both of the task force trials should be completed in 1979. 
Improvement of the service delivery 
of methods based on periodic abstinence 
The educational component of methods based on periodic absti-
nence plays an even more important role than in other methods of 
family planning. The extremely wide range of unplanned pregnancies 
reported for these methods (approximately 0.8-26 pregnancies per 
100 women-years as calculated by the Pearl Index) may be due in part 
to the quality of the instruction provided. 
The major emphasis of the work of the task force in this area is to 
develop, field test and evaluate educational materials (an NFP "Learn-
ing Package") which would form the core of a standardized curricu-
lum for instructing NFP non-physician teachers (from nurses to lay 
members of the community and user-couples) in the use of the two 
currently most widely practiced methods based on periodic 
abstinence - the ovulation method and the sympto-thermal method. 
The methodology for the development of the NFP Learning Pack-
age, called the " Family Fertility Education Learning Package," was 
designed in December, 1975 in consultation with three NFP consult-
ants. It consisted essentially of four major stages: 
1. Broad consultation with 30 NFP programs (groups or organiza-
tions actively engaged in teaching NFP) with both a program 
survey and curriculum questionnaire with the curriculum ques-
tionnaire being also sent to a further 10 control groups (indi-
vidual experts conversant in all methods of fertility regulation). 
2. Two face-to-face consultations on the NFP teaching objectives 
and the development of the learning package were held in 
November, 1976 with 14 investigators from 11 countries per-
mitting the British Life Assurance Trust (BLAT), the Center for 
Health and Medical Education of the British Medical Association 
and a WHO collaborating center for educational technology, to 
proceed and develop a prototype NFP Learning Package which 
includes a guide to teaching and 4 NFP modules or method man-
uals dealing with: 
- Fertility Awareness 
- Sexuality and Responsibility 
- Ovulation Method 
- Sympto-thermal Method 
3. The pre-test and evaluation of the NFP Learning Package in six 
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countries are currently being done in Canada, Colombia, Kenya, 
Philippines, South Korea, United Kingdom. 
4. The preparation of a second generation improved NFP Learning 
Package. 
Evaluation of physiological events 
relating to the fertile period 
During the past several years researchers in human reproduction 
have assumed primarily from circumstantial evidence that ovulation 
occurs approximately 18-24 hours after the LH peak. Aside from a 
few isolated projects on small groups of women, there has not been 
any major study performed to obtain a truly accurate estimation of 
the occurrence of ovulation in relation to changes in several hormonal 
parameters. Such information would, of course, be extremely useful 
to all areas of laboratory and clinical research in human reproduction 
concerned with ovulation. More importantly, in terms of the objec-
tives of the task force, this information is vital as it should lead to the 
identification of hormonal parameters which could be used as refer-
ence points to judge the reliability of methods developed for the 
prediction of ovulation which are suitable for home use. 
During 1977, a 10 center study was completed. It had begun in 
1975 on the correlation between ovulation, as determined by observa-
tion of the ovaries at laparotomy, and plasma levels of steroids and 
gonadotrophins in women. Data from approximately 185 cases is 
presently being analyzed and should provide accurate information on 
the time interval between ovulation and the LH, FSH and estradiol 
peaks and the first significant rises of these hormones as well as for 
progesterone. 
At the May 16-19, 1978 task force meeting, preliminary results 
from 99 cases were presented by Dr. B. William Collins of London, 
coordinator of the study. The relationship of the LH peak to ovula-
tion revealed no greater precision than earlier studies; 90% of ovula-
tions appeared to occur from 20 hours before to 68 hours after the LH 
peak. 
A method that predicts the time of ovulation and does not also take 
into account the fertilizing life span of spermatozoa will lead to fail-
ures since viable sperm may still be present from coitus which oc-
curred before the immediate peri ovulatory period. Relatively little is 
known about the fertile life span of the gametes in humans and there 
is no practical way of ascertaining it precisely for the individual 
couple. Last year the task force supported a study aimed at evaluating 
the fertilizing life span of spermatozoa and the fertilizable life span of 
ova by retrospective analysis of charts obtained from women who 
became pregnant while practicing methods of family planning which 
require temperature recording. 
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This exploratory study of Dr. M. Bourdais, from France, was 
reported on at the May, 1978 meeting and its findings and analysis of 
some 2,300 pregnancy cycles in three different populations (France, 
Mauritius, Colombia) were reviewed by the steering committee. 
Quality of data problems were encountered in such a retrospective 
approach, both in the charting of the BBT shift (the majority of which 
had no correlating mucus symptoms) or with the exact recording of 
intercourses and the data was classified accordingly. A reference point 
for the analysis of the BBT shift was arbitrarily chosen as the first day 
of the confirmed hyperthermallevel and designated as day +1. 
Although occasional rare conceiving intercourses were observed in 
the -10 to -15 day range before the BBT shift (1% from -12 to -15 
inclusive) and (4% from -9 -10 -11 days) the majority of the observa-
tions revealed that 95% of all pregnancies resulted from intercourses 
occurring between the -8 to +1 days and 85% of all pregnancies from 
-5 to +1 days giving a very indirect idea of the nature of the fertile 
period. 
It was felt that in order to obtain a truer reflection of the fertile 
period, based on the fertility rate of intercourses occurring in different 
days before the BBT shift or around the peak mucus symptom, both a 
better association or relationship of these reference days to the 
physiological events should be established and a large prospective 
study would be necessary. However, serious methodological problems 
may preclude the conduct of such a study at this time. 
Assay Kit Development 
The main objective of the work supported in this area is to develop 
kits suitable for home use, primarily in developing countries, which 
will permit women to predict and detect the occurrence of ovulation. 
The task force is trying to devise, for example, a "test-tape" or "dip 
and read" stick system which measures the concentration of a specific 
compound in urine and signals in an unambiguous manner "yes" or 
"no" as to whether a woman is entering a fertile period. 
Program efforts have been directed towards the identification of 
potentially useful markers in readily accessible body fluids, i.e., urine, 
saliva and cervical mucus. 
Urine 
a. estrogen and pregnanediol glucuronides 
Follicular development leading to ovulation is associated with 
increased secretion of estradiol and rapidly increasing levels of cir-
culating estrogens initiate the LH surge which precedes ovulation. 
Since a relatively large percentage of the circulating estrogeris are 
excreted in the urine over a period of 24 hours the measurement of 
conjugated estrogen metabolites should provide a means of predicting 
ovulation. Because the relative proportions of the individual estrogen 
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metabolites were not known, in 1975 the task force began preparing 
specific reagents (antisera, standards, etc.) which were required for the 
development of radioimmunoassays to measure the following com-
pounds in samples of unextracted diluted urine: estrone-3-glu-
curonide, estradiol-3-glucuronide, estriol-3-glucuronide, estradiol-17B-
glucuronide and estriol-16a-glucuronide. 
During 1976-1977, the methods developed were applied to serial 
samples of urine collected throughout the menstrual cycle from ovula-
tory women . The preliminary results indicate that for the prediction 
of ovulation, the excretion patterns of estriol-16a-glucuronide and 
estrone-3-glucuronide were more consistent and had better defined 
peaks than those of estradiol-3-glucuronide, estradiol-17 fJ -glucuronide 
and estriol-3-glucuronide. The concentrations of estriol-16a-glu-
curonide and estrone-3-glucuronide significantly increase above base-
line values approximately 3 to 4 days before the LH peak, respec-
tively, i.e., approximately 4 to 5 days before ovulation. 
An increase in the concentration in urine of pregnanediol-3a-glu-
curonide is a good indication that ovulation has occurred. Reagents 
were prepared by the task force for the measurement of this 
metabolite of progesterone by radioimmunoassay in un extracted 
diluted urine. The method was applied by four groups of workers to 
serial samples of urine obtained during 33 ovulatory menstrual cycles. 
The preliminary results indicate that a significant rise above mean 
baseline values occurs around two days after the LH peak, that there is 
a reasonable correlation between the values obtained for the 24 hour 
collection and the early morning specimens and that there is a good 
possibility of defining "universal" threshold values indicative of ovula-
tion. The mean values of pregnanediol-3aglucuronide during the fol-
licular and luteal phase of the menstrual cycle were found to be 
approximately 3 nmol/24 and 17 nmol/24h., respectively. Thus, there 
appears to be at least five-fold increase in the compound after ovula-
tion. These findings indicate that the measurement of pregnanediol-
3a-glucuronide may provide a practical means for detecting the end of 
the fertile period and the beginning of the postovulatory infertile 
phase of the menstrual cycle. 
The results from the work on estrogen and pregnanediol glu-
curonides imply that, pending the ability to develop immunological 
assay systems not requiring the use of radioactive markers, estrone-3-
glucuronide, estriol-l6a-glucuronide and pregnanediol-3a-glucuronide 
could potentially form the basis of a "do-it-yourself" kit to predict 
and detect the occurrence of ovulation early enough to account for 
the fertilizing lifespan of spermatozoa. Presently, additional studies 
are being conducted by nine groups in different geographical settings 
to determine if the findings obtained to date are representative of 
women throughout the world. Specifically, these additional studies 
seek to obtain data on the inter-women and the intra-woman variation 
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in the excretion pattern of these metabolites, the correlation between 
the concentrations obtained in early morning and 24 hour samples and 
the temporal relationship between the first significant rise and peak of 
the metabolites and ovulation. 
It is anticipated that collaboration with industry on the develop-
ment of kits suitable for home use will begin during 1979-80. 
To confirm the feasibility of developing such an approach to urin-
ary assay kits for the fertile period, a two-phase study comparing 
urinary assays with existing NFP method signals (OM and ST param-
eters) will be launched by the end of 1978 or early 1979, attempting, 
if possible, to recruit a few selected participants willing to observe 
their planned pregnancies and post partum return of fertility. 
b. LH 
The objective of this approach is to investigate the usefulness of 
urinary LH measurements as a means of detecting ovulation. Although 
LH reaches its maximum level prior to ovulation, the measurement of 
this hormone would not operationally permit the prediction of ovula-
tion as the peak does not occur early enough to allow for the fertiliz-
ing lifespan of spermatozoa. Previously a task force investigator dem-
onstrated that the radioreceptorassay for human chorionic gonadotro-
phin shows an equal affinity for LH and was capable of successfully 
detecting the mid-cycle LH peak in urine. The assay, which has a 
sensitivity for LH of 50 pg/ml of untreated urine, shows levels of 3-4 
ng/ml during the early follicular phase and mean mid-cycle levels of 
about 40 ng/ml. 
In order to avoid the use of radioactive ligands and render the assay 
suitable for home use, attempts are presently being made to develop 
an enzyme receptorassay which would give a color change as the end-
point. 
Device Development 
In an attempt to develop devices which could be used to precisely 
and reliably predict ovulation, some of the techniques used by bio-
engineers (e.g., photoplethysmography) have been applied to an 
investigation of the menstrual cycle. Although the preliminary results 
obtained appear to indicate that ovulation could be detected by 
measuring, for example, changes in vaginal thermal conductivity, light 
reflectance and impedance, it was decided that the techniques used 
could probably not be transformed into devices which would be 
acceptable and suitable for home use, especially in developing coun-
tries. Nevertheless, the task force will continue some research in this 
area as the approaches being investigated may lead to the identificat-
ion of physical parameters which could be used by clinicians as a 
reference point for determining the time of ovulation. 
The clinical evaluation of a biopotential meter (not developed by 
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WHO) reputed to be capable of detecting ovulation was undertaken in 
1976. The meter was designed to measure changes in polarity and 
magnitude of electrical potential of the body, ovulation being indi-
cated by a reversal of polarity. In only 1 of 35 ovulatory cycles was a 
change in polarity recorded around the time of ovulation. A change in 
the magnitude of the potential or polarity unrelated to the time of 
ovulation was recorded in 5 of the 35 cycles studied. In short, the 
meter used (which was apparently representative of a number of such 
meters presently receiving publicity in the press) showed no significant 
or consistent pattern of change in polarity or potential which could be 
correlated with cervical mucus symptoms or the BBT shift associated 
with ovulation. 
At present the Task Force is exploring the possibility of developing 
electronic techniques and instrumentation in an attempt to replace the 
clinical or basal body temperature thermometer, and the necessity to 
graph results, by a more acceptable, simple and convenient means to 
detect the post-ovulatory shift in temperature. Advances in "pocket 
calculator" technology are such that it now appears feasible to make 
very simple inexpensive instruments which could, for example, 
instantaneously take a temperature reading, automatically record it 
and, at the push of a button, display a sequence of eight previous 
recordings, plot a graph, or indicate, with a red or green light, if the 
temperature shift has occurred. 
Conclusion 
In conclusion, the WHO Task Force on Methods for the Determina-
tion of the Fertile Period is supporting research that aims at assessing 
in different cultures the currently available methods of family 
planning based on periodic abstinence and at improving their pro-
vision. Concurrently, studies are also being pursued to accurately 
determine the duration of the fertile period and to develop "do-it-
yourself" methods to predict and detect ovulation which would be 
suitable for home use in developing countries. The work of the Task 
Force requires the participation of scientists from a variety of disci-
plines including reproduction physiology, obstetrics and gynecology, 
chemistry, bioengineering, natural family planning and education and 
should provide valuable information to all areas of human repro-
duction. 
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